Importance of Self-Motivation and Social Support in Medication Adherence in HIV-Infected Adolescents in the United Kingdom and Ireland: A Multicentre HYPNet Study

AIDS Patient Care and STDs

Volumn 29, Issue 6, 2015, Pages 354-364

  Kim, Sung Hee ^a   McDonald, Susan ^b   Kim, Samuel ^a   Foster, Caroline ^b   Fidler, Sarah ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTI-HIV AGENTS;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FAMILY; FEMALE; FRIEND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRELAND; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MOTIVATION; MULTICENTER STUDY; PEER GROUP; PROFESSIONAL PRACTICE; SELF CONCEPT; SELF MOTIVATION; SELF REPORT; SOCIAL SUPPORT; STIGMA; SUPPORT GROUP; TREATMENT DURATION; UNITED KINGDOM; YOUNG ADULT; AGE DISTRIBUTION; CLINICAL TRIAL; CROSS-SECTIONAL STUDIES; GREAT BRITAIN; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; URBAN POPULATION;

ADOLESCENT; AGE DISTRIBUTION; ANTI-HIV AGENTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HIV INFECTIONS; HUMANS; IRELAND; MALE; MEDICATION ADHERENCE; MOTIVATION; QUESTIONNAIRES; RISK FACTORS; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84930145932     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2014.0335     Document Type: Article

References (27)

1. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-941.
2. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-366.
3. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America. JAMA 2006;296:679-690.
4. El-Sadr W, Lundgren JD, Neaton J, et al. CD4 + count-guided interruption of antiretroviral treatment. New Engl J Med 2006;355:2283-2296.
5. Organisation WH. Adolescent Health. 2014 [cited 2014 24/09/2014]; Available from: http://www.who.int/topics/adolescent-health/en/
6. Kim S-H, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: Systematic review and meta-analysis. AIDS 2014;28:1945-1956.
7. Brown LK, Lourie KJ. Children and adolescents living with HIV and AIDS: A review. J Child Psychol Psychiatry 2000;41:81-96.
8. HYPNet. HYPNet Adherence Guidelines 2013. 2013 [cited 2014 07/10/2014]; Available from: http://www.hypnet.org.uk/pages/documents.php
9. Intasan J, Bunupuradah T, Vonthanak S, et al. Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial. AIDS Patient Care STDs 2014;28:296-302.
10. Eisen S, Barkley L, Schepers C, et al. Impact of transition to adult services on clinic attendance and virological control in HIV-infected adolescents. HIV Med 2009;10:45.
11. Elgalib A, Samarawickrama A, Roedling S, et al. Pregnancies in HIV-infected adolescents: A multicentre descriptive study. HIV Med 2009;10:4.
12. Ellis J, Norrish G, Elgalib A. HIV positive adolescents: Characteristics and treatment challenges. HIV Med 2012;13:38.
13. Williams PL, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006;118:e1745-e1757.
14. McQuaid EL, Kopel SJ, Klein RB, Fritz GK. Medication adherence in pediatric asthma: Reasoning, responsibility, and behavior. J Pediatr Psychol 2003;28:323-333.
15. Saitoh A, Foca M, Viani RM, et al. Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection. Pediatrics 2008;121:e513-e521.
16. Klein N, Sefe D, Mosconi I, et al. The immunological and virological consequences of planned treatment interruptions in children with HIV infection. PloS One 2013;8:e76582.
17. Bamford A, Turkova A, Lyall H, et al. Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: Optimising health in preparation for adult life. HIV Med 2015 Feb 3. doi: 10/1111/hiv.12217. [Epub ahead of print].
18. World Health Organisation. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2014.
19. Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - A systematic review. HIV Med 2013;14:583-595.
20. Hill S, Kavookjian J. Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: A systematic review of the literature. AIDS Care 2012;24:583-592.
21. Foster C, McDonald S, Frize G, Ayers S, Fidler S. "Payment by Results" - Financial incentives and motivational interviewing, adherence interventions in young adults with perinatally acquired HIV-1 infection: A pilot program. AIDS Patient Care STDs 2014;28:28-32.
22. Trocme N, Vaudre G, Dollfus C, Leverger G. [Factors impacting on antiretroviral therapy compliance in HIV positive adolescents]. Arch Pediatr 2002;9:1241-1247.
23. Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: A randomized controlled trial of text message reminders. AIDS 2011;25:825.
24. Perera AI, Thomas MG, Moore JO, Faasse K, Petrie KJ. Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: A randomized clinical trial. AIDS Patient Care STDs 2014;28:579-586.
25. Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: A randomized controlled trial. J AIDS (1999) 2009;52:465-473.
26. CDC. Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention. 2013 [cited 2014 25/09/2014]; Available from: http://www.cdc.gov/hiv/prevention/research/compendium/ma/peersupport.html
27. Funck-Brentano I, Dalban C, Veber F, et al. Evaluation of a peer support group therapy for HIV-infected adolescents. AIDS 2005;19:1501-1508.